BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24022213)

  • 1. p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
    Felisiak-Golabek A; Dansonka-Mieszkowska A; Rzepecka IK; Szafron L; Kwiatkowska E; Konopka B; Podgorska A; Rembiszewska A; Kupryjanczyk J
    Cancer Biol Ther; 2013 Oct; 14(10):973-81. PubMed ID: 24022213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.
    Kannan K; Coarfa C; Rajapakshe K; Hawkins SM; Matzuk MM; Milosavljevic A; Yen L
    PLoS Genet; 2014 Mar; 10(3):e1004216. PubMed ID: 24675677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypyrimidine tract-binding protein induces p19(Ink4d) expression and inhibits the proliferation of H1299 cells.
    Lin S; Wang MJ; Tseng KY
    PLoS One; 2013; 8(3):e58227. PubMed ID: 23536791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
    Salmena L; Shaw P; Fans I; McLaughlin ; Rosen B; Risch H; Mitchell C; Sun P; Narod SA; Kotsopoulos J
    Eur J Gynaecol Oncol; 2015; 36(3):260-7. PubMed ID: 26189250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
    Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
    Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.
    Kupryjanczyk J; Kraszewska E; Ziolkowska-Seta I; Madry R; Timorek A; Markowska J; Stelmachow J; Bidzinski M;
    BMC Cancer; 2008 Jan; 8():27. PubMed ID: 18230133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.
    Felisiak-Golabek A; Rembiszewska A; Rzepecka IK; Szafron L; Madry R; Murawska M; Napiorkowski T; Sobiczewski P; Osuch B; Kupryjanczyk J;
    J Ovarian Res; 2011 Nov; 4(1):20. PubMed ID: 22075440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic Expression and Function of the
    Doherty JR; Nilsson LM; Kuliyev E; Zhu H; Matthew R; Cleveland JL; Mead PE; Roussel MF
    Cell Dev Biol; 2014 Feb; 3(1):. PubMed ID: 25309971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
    Kang EY; Cheasley D; LePage C; Wakefield MJ; da Cunha Torres M; Rowley S; Salazar C; Xing Z; Allan P; Bowtell DDL; Mes-Masson AM; Provencher DM; Rahimi K; Kelemen LE; Fasching PA; Doherty JA; Goodman MT; Goode EL; Deen S; Pharoah PDP; Brenton JD; Sieh W; Mateoiu C; Sundfeldt K; Cook LS; Le ND; Anglesio MS; Gilks CB; Huntsman DG; Kennedy CJ; Traficante N; ; DeFazio A; Kaufmann S; Churchman M; Gourley C; Stephens AN; Meagher NS; Ramus SJ; Antill YC; Campbell I; Scott CL; Köbel M; Gorringe KL;
    Mod Pathol; 2021 Jan; 34(1):194-206. PubMed ID: 32724153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19
    Qu M; Fang F; Zou X; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
    Cell Death Dis; 2016 Oct; 7(10):e2430. PubMed ID: 27763644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis.
    Buchold GM; Magyar PL; Arumugam R; Lee MM; O'Brien DA
    Mol Reprod Dev; 2007 Aug; 74(8):997-1007. PubMed ID: 17342741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.
    Han X; Zhang J; Peng Y; Peng M; Chen X; Chen H; Song J; Hu X; Ye M; Li J; Sankaran VG; Hillyer CD; Mohandas N; An X; Liu J
    Blood; 2017 Jan; 129(2):226-237. PubMed ID: 27879259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation-induced unfolding regulates p19
    Kumar A; Gopalswamy M; Wolf A; Brockwell DJ; Hatzfeld M; Balbach J
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3344-3349. PubMed ID: 29531090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.
    Ziółkowska-Seta I; Madry R; Kraszewska E; Szymańska T; Timorek A; Rembiszewska A; Kupryjańczyk J
    Gynecol Oncol; 2009 Jan; 112(1):179-84. PubMed ID: 18937971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.
    Rzepecka IK; Szafron LM; Stys A; Felisiak-Golabek A; Podgorska A; Timorek A; Sobiczewski P; Pienkowska-Grela B; El-Bahrawy M; Kupryjanczyk J
    Gynecol Oncol; 2017 Feb; 144(2):369-376. PubMed ID: 27939982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1.
    Gilles L; Guièze R; Bluteau D; Cordette-Lagarde V; Lacout C; Favier R; Larbret F; Debili N; Vainchenker W; Raslova H
    Blood; 2008 Apr; 111(8):4081-91. PubMed ID: 18276842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging.
    Hilpert M; Legrand C; Bluteau D; Balayn N; Betems A; Bluteau O; Villeval JL; Louache F; Gonin P; Debili N; Plo I; Vainchenker W; Gilles L; Raslova H
    Stem Cell Reports; 2014 Dec; 3(6):1085-102. PubMed ID: 25458892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.